News

Devyser at DGTI 2020

Come and visit our virtual booth at DGTI! The 53rd annual meeting in Immunohaematology and Transfusion Medicine is taking place virtually from September 16th to 18th 2020. Visit our virtual booth to learn more about our upcoming solution for the non-invasive detection of fetal RHD status as well as Devyser Chimerism, our chimerism monitoring solution. …

Devyser at DGTI 2020 Read More »

Devyser’s breakthrough NGS product for hereditary breast and ovarian cancer testing now approved for diagnostic use in the EU

Stockholm, 22 July 2020 —Swedish genetic test developer Devyser’s product for hereditary breast and ovarian cancer (HBOC) is now CE labelled and approved for diagnostic use in the EU. The kit is based on Devyser’s patented next-generation sequencing library prep technology and provides targeted sequencing of 12 genes with a recognized connection to the development …

Devyser’s breakthrough NGS product for hereditary breast and ovarian cancer testing now approved for diagnostic use in the EU Read More »

Discover Devyser CFTR 68

https://vimeo.com/434385139/77bd5832b6 Discover Devyser CFTR 68, our latest kit for the analysis of the CFTR gene, capable of detecting up to 68 mutations most commonly associated with Cystic Fibrosis. List of mutations detected by Devyser CFTR 68 711+ 1G>T, 2043delG, 1677delTA, W1282X, R1283M, K710X, 3849+10kbC>T, 2789+5G>A, M1101K, G85E, 3905insT, 1525-1G>A, 2184delA, 3659delC, N1303K, 2184insA, 1812-1G->A, CFTRdele2,3, …

Discover Devyser CFTR 68 Read More »

Devyser gears up for global sales of genetic tests — recruits Torbjörn Andersson as Chief Commercial Officer

Stockholm, 26 may 2020 — Devyser welcomes Torbjörn Andersson as Chief Commercial Officer in charge of global sales and marketing of Devyser’s genetic tests. Torbjörn has extensive experience in building and leading international sales organisations and distributor networks in the life science industry. He joins us most recently from Biotage AB where he was the Head …

Devyser gears up for global sales of genetic tests — recruits Torbjörn Andersson as Chief Commercial Officer Read More »

EFI 2020 postponed

Unfortunately, the EFI 2020 conference has been postponed due to the current COVID-19 pandemic concerns. Another date will be communicated to us soon! Meanwhile, let us know if you have any questions about our Chimerism NGS solutions or any of our other products and we will be happy to answer you. Link to EFI’s commitee …

EFI 2020 postponed Read More »

Today is World Cancer Day

Today is World Cancer Day, as advocated by the Union for International Cancer Control. Their global advocacy for “Treatment For All”, includes 4 important pillars – Improved public health data, early diagnosis, timely treatment, and supportive care.